Ankylosing spondylitis Trials in Duncansville, United States
Conditions / Ankylosing spondylitis / Duncansville, United States
Ankylosing spondylitis has been the subject of sustained clinical investigation across multiple research sites.
20 total trials for this combination
Showing top 10 of 20 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT03259074 | Effect of Secukinumab on Radiographic Progression in Ankylosing Spondylitis as Compared to GP2017 (Adalimumab Biosimilar) | COMPLETED | PHASE3 |
| NCT00643526 | A Study to Test the Design, Functionality, and Ergonomic Features of the Autoinjector | COMPLETED | EARLY_PHASE1 |
| NCT02538341 | Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial) | COMPLETED | PHASE2 |
| NCT02963506 | A Study to Evaluate the Efficacy and Safety of Different Doses of Bimekizumab in Subjects With Active Ankylosing Spondylitis | COMPLETED | PHASE2 |
| NCT03502616 | Efficacy and Safety of Tofacitinib in Subjects With Active Ankylosing Spondylitis (AS) | COMPLETED | PHASE3 |
| NCT04436640 | A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Subjects With Active Axial Spondyloarthritis Including Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis | ACTIVE_NOT_RECRUITING | — |
| NCT03350815 | Study Estimating the Clinical Difference Between 300 mg and 150 mg of Secukinumab Following Dose Escalation to 300 mg in Patients With Ankylosing Spondylitis | COMPLETED | PHASE4 |
| NCT02505542 | Study to Evaluate Maintenance of Sustained Remission of axSpA With CZP Compared to Placebo | COMPLETED | PHASE3 |
| NCT03928743 | A Study to Evaluate the Efficacy and Safety of Bimekizumab in Subjects With Active Ankylosing Spondylitis | COMPLETED | PHASE3 |
| NCT01061723 | Dose Ranging Study to Evaluate the Efficacy and Safety of SAR153191 (REGN88) in Patients With Ankylosing Spondylitis | COMPLETED | PHASE2 |